| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Surgical and Radiological Sciences (DL, GDK, PJD, RAL) and Pathology, Microbiology, and Immunology (RJH) and Veterinary Medical Teaching Hospital (DKN), School of Veterinary Medicine, University of California–Davis, Davis, CA; and Department of Pathology, School of Medicine, University of California–San Francisco, San Francisco, CA (AWB)
Although glioblastoma multiforme (GBM), a World Health Organization grade IV astrocytoma, is the most common primary brain tumor in humans, in dogs GBM is relatively rare, accounting for only about 5% of all astrocytomas. This study presents combined clinical, neuroimaging, and neuropathologic findings in five dogs with GBM. The five dogs, aged from 5 to 12 years, were presented with progressive neurologic deficits that subsequent clinical neurologic examination and neuroimaging studies by magnetic resonance imaging (MRI), localized to space occupying lesions in the brain. MRI features of the tumors included consistent peritumoral edema (n = 5), sharp borders (n = 4), ring enhancement (n = 3), heterogenous T2-weighted signal intensity (n = 3), iso- to hypointense T1-weighted images (n = 5), necrosis (n = 5), and cyst formation (n = 2). Two tumors were diagnosed clinically using a computed tomography–guided stereotactic biopsy procedure. At necropsy all the tumors resulted in, on transverse sections, a prominent midline shift and had a variegated appearance due to intratumoral necrosis and hemorrhage. Histologically, they had serpentine necrosis with glial cell pseudopalisading and microvascular proliferation, features which distinguish human GBM from grade III astrocytomas. Immunoreactivity of tumor cells for glial fibrillary acidic protein was strongly positive in all cases, whereas 60% and 40% of the tumors also expressed epidermal growth factor receptor and vascular endothelial growth factor, respectively. These canine GBMs shared many diagnostic neuroimaging, gross, microcopic, and immunoreactivity features similar to those of human GBMs.
Key words: Astrocytoma; brain tumor; EGFR; glioblastoma multiforme; immunocytochemistry; magnetic resonance imaging; VEGF.
Request reprints from Dr. R. J. Higgins, Department of Pathology, Microbiology, and Immunology, Haring Hall, School of Veterinary Medicine, University of California–Davis, Davis, CA 95616 (USA). E-mail: rjhiggins{at}ucdavis.edu.
This article has been cited by other articles:
 |
|
 |
|
  P. J. Dickinson, B. K. Sturges, R. J. Higgins, B. N. Roberts, C. M. Leutenegger, A. W. Bollen, and R. A. LeCouteur Vascular Endothelial Growth Factor mRNA Expression and Peritumoral Edema in Canine Primary Central Nervous System Tumors Vet. Pathol., March 1, 2008; 45(2): 131 - 139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Marioni-Henry, T. Schwarz, C. Weisse, and K. B. Muravnick Cystic Nasal Adenocarcinoma in a Cat Treated With Piroxicam and Chemoembolization J. Am. Anim. Hosp. Assoc., November 1, 2007; 43(6): 347 - 351. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Candolfi, G. E. Pluhar, K. Kroeger, M. Puntel, J. Curtin, C. Barcia, A.K.M. G. Muhammad, W. Xiong, C. Liu, S. Mondkar, et al. Optimization of adenoviral vector-mediated transgene expression in the canine brain in vivo, and in canine glioma cells in vitro Neuro-oncol, July 1, 2007; 9(3): 245 - 258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kimmelman and J. Nalbantoglu Faithful Companions: A Proposal for Neurooncology Trials in Pet Dogs Cancer Res., May 15, 2007; 67(10): 4541 - 4544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. A. M. Thomson, E. Kennerly, N. Olby, J. R. Mickelson, D. E. Hoffmann, P. J. Dickinson, G. Gibson, and M. Breen Microarray Analysis of Differentially Expressed Genes of Primary Tumors in the Canine Central Nervous System Vet. Pathol., September 1, 2005; 42(5): 550 - 558. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
